Date: 2018-01-17

Type of information: Nomination

Compound: vice-president

Company: Synpromics (UK)

Therapeutic area: Technology - Services

Type agreement: nomination

Action mechanism:



  • • On January 17, 2018, Synpromics, a leader in gene control, announced the appointment of Sarah Haecker Meeks to the position of Vice President, Business Development. Dr. Haecker Meeks brings a deep expertise in emerging technologies and business strategy focused on the design and development of gene medicines and will lead business development for the company.
  • Synpromics has also established a new US subsidiary, Synpromics Inc. and Sarah will lead business development activities from the US covering all territories.

Financial terms:

Latest news:

Is general: Yes